LGC Maine Standards, Cumberland Foreside, Maine, an international life sciences measurement and testing company, has released the Validate heparin linearity and calibration verification kit for Siemens Sysmex analyzers.
The Validate heparin kit evaluates assays for heparin anti-Xa, a marker used to measure a patient’s heparin level based on its specific inhibition of Factor X in the blood. Supplied in a human plasma matrix, the Validate heparin solutions are provided in a liquid, ready-to-use format prepared using the Clinical and Laboratory Standards Institute’s EP06-A ‘equal delta’ sample preparation method, and offering five distinct concentrations to cover the reportable range. Users dispense the solutions from each dropper bottle directly into five sample cups, and run in replicates.
The release of Validate heparin for Siemens Sysmex analyzers enables clinical laboratories to complete required heparin anti-Xa linearity and calibration verification, maximizing the reportable range of their assays while minimizing manual dilutions. Use of the product assists with fulfilling various quality control requirements, such as reportable range and analytical measurement range for linearity and calibration verification, as required under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and other certification standards.
The addition of Validate heparin for Siemens Sysmex analyzers to the expanding portfolio of products from LGC Maine Standards demonstrates a continued commitment to manufacturing high-quality linearity and calibration verification products that meet industry needs. Available Validate linearity and calibration verification kits cover more than 130 analytes, including anemia, cardiac markers, enzymes, fertility, general chemistries, HbA1c, hemostasis lipids, serum proteins, therapeutic drugs, thyroid markers, tumor markers, urine chemistries, vitamin D, and whole blood glucose.
To learn more, visit LGC Maine Standards.
